Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$17,500.00

Modelling CAR-T cell function using a 3D in vitro model of the tumour microenvironment

EF 2021-22

Résumé
Cancer affects a substantial portion of the Canadian population; however, a universal cure remains elusive. Recent approaches to cancer treatment have focused on T cells, an important type of immune cell that helps to attack cancerous and virally infected cells. A novel treatment approach, termed CAR-T cell therapy, involves re-engineering T cells to recognize and target tumours. While this approach has achieved remarkable success in treating blood cancers, the efficacy has been substantially reduced in patients with solid tumours, owing to the immunosuppressive nature of the tumour microenvironment. This phenomenon can be studied in animal models to a certain extent; however, the high costs and long duration of animal studies limits the capacity for iterative improvement of CAR-T cell design. The proposed work aims to develop a solid tumour-on-a-chip platform designed to evaluate CAR-T cell function. To provide a more accurate representation of the tumour microenvironment, this platform will modularly incorporate key immunosuppressive features, including dysregulated blood vessels and oxygen deprivation, such that the influence of each feature can be studied independently. This work will provide insight into how various immunosuppressive features in the tumour microenvironment contribute to CAR-T cell dysfunction, enabling the development of improved CAR-T cell therapies for solid tumour patients.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
466802
Name
Durland Lauren
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Modelling CAR-T cell function using a 3D in vitro model of the tumour microenvironment
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cancer Therapy; Car-T Cell Therapy; Immunotherapy; Models Of The Tumor Microenvironment; Organ-On-A-Chip
Abstract
Cancer affects a substantial portion of the Canadian population; however, a universal cure remains elusive. Recent approaches to cancer treatment have focused on T cells, an important type of immune cell that helps to attack cancerous and virally infected cells. A novel treatment approach, termed CAR-T cell therapy, involves re-engineering T cells to recognize and target tumours. While this approach has achieved remarkable success in treating blood cancers, the efficacy has been substantially reduced in patients with solid tumours, owing to the immunosuppressive nature of the tumour microenvironment. This phenomenon can be studied in animal models to a certain extent; however, the high costs and long duration of animal studies limits the capacity for iterative improvement of CAR-T cell design. The proposed work aims to develop a solid tumour-on-a-chip platform designed to evaluate CAR-T cell function. To provide a more accurate representation of the tumour microenvironment, this platform will modularly incorporate key immunosuppressive features, including dysregulated blood vessels and oxygen deprivation, such that the influence of each feature can be studied independently. This work will provide insight into how various immunosuppressive features in the tumour microenvironment contribute to CAR-T cell dysfunction, enabling the development of improved CAR-T cell therapies for solid tumour patients.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Durland, Lauren
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~